US approves sickle cell breakthrough with gene editing therapy
The United States has approved breakthrough gene editing therapy using the CRISPR tool to treat sickle cell disease. This is a major advancement in gene therapy for patients with sickle cell disease, which affects over 100,000 Americans, mostly Black individuals. The therapy was approved by the US Food and Drug Administration and uses Nobel Prize-winning…